NO20065722L - Medisinske aerosolformuleringsprodukter med forbedret kjemisk stabilitet. - Google Patents

Medisinske aerosolformuleringsprodukter med forbedret kjemisk stabilitet.

Info

Publication number
NO20065722L
NO20065722L NO20065722A NO20065722A NO20065722L NO 20065722 L NO20065722 L NO 20065722L NO 20065722 A NO20065722 A NO 20065722A NO 20065722 A NO20065722 A NO 20065722A NO 20065722 L NO20065722 L NO 20065722L
Authority
NO
Norway
Prior art keywords
aerosol formulation
chemical stability
improved chemical
linking agent
butyl rubber
Prior art date
Application number
NO20065722A
Other languages
English (en)
Inventor
David Lewis
Brian John Meakin
Tanya Kathleen Church
Robert Johnson
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of NO20065722L publication Critical patent/NO20065722L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)

Abstract

Medisinsk produkt i form av aerosolformulering med forbedret kjemisk stabilitet, omfattende en trykksatt inhalator som gir utmålt dose, som omfatter en aerosolkanister utstyrt med en doseringsventil anordnet med forseglingsringer og/eller pakninger fremstilt av et vulkanisat av et elastomer materiale av en butylgummi, et tverrbindingsmiddel for butylgummien og en akselerator for tverrbindingsmidlet, hvor akseleratoren innbefatter en polysulfidforbindelse avledet fra en substituert ditiokarbonsyre eller et derivat av denne, hvor den trykksatte inhalator som gir utmålt dose inneholder i aerosolkanisteren en medisinsk aerosolformulering som inneholder en langtidsvirkende P2-agonist, et hydrogenfluorkarbondrivmiddel, et ko-løsningsmiddel og en mineralsyre som stabilisator for den aktive bestanddel.
NO20065722A 2004-05-13 2006-12-12 Medisinske aerosolformuleringsprodukter med forbedret kjemisk stabilitet. NO20065722L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04011425 2004-05-13
PCT/EP2005/002041 WO2005112902A2 (en) 2004-05-13 2005-02-25 Medicinal aerosol formulation products with improved chemical stability

Publications (1)

Publication Number Publication Date
NO20065722L true NO20065722L (no) 2006-12-12

Family

ID=34960892

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065722A NO20065722L (no) 2004-05-13 2006-12-12 Medisinske aerosolformuleringsprodukter med forbedret kjemisk stabilitet.

Country Status (19)

Country Link
US (1) US20070086953A1 (no)
EP (1) EP1746981B1 (no)
JP (1) JP2007537170A (no)
KR (1) KR20070010159A (no)
CN (1) CN1950075A (no)
AT (1) ATE404185T1 (no)
AU (1) AU2005245248A1 (no)
BR (1) BRPI0510852A (no)
CA (1) CA2565747A1 (no)
DE (1) DE602005008946D1 (no)
EA (1) EA200602112A1 (no)
ES (1) ES2309722T3 (no)
IL (1) IL178739A0 (no)
MA (1) MA28649B1 (no)
MX (1) MXPA06013189A (no)
NO (1) NO20065722L (no)
TN (1) TNSN06334A1 (no)
WO (1) WO2005112902A2 (no)
ZA (1) ZA200608742B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TN2016000261A1 (en) * 2013-12-30 2017-10-06 Chiesi Farm Spa Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination.
ES2666905T4 (es) 2013-12-30 2018-06-07 Chiesi Farmaceutici S.P.A. Composición en solución para aerosol estable presurizada de una combinación de bromuro de glicopirronio y formoterol
CN106620976B (zh) * 2016-12-28 2020-01-07 四川普锐特医药科技有限责任公司 一种丙酸氟替卡松定量吸入气雾剂
GB202001537D0 (en) * 2020-02-05 2020-03-18 Consort Medical Plc Pressurised dispensing container
US20230277451A1 (en) * 2020-10-09 2023-09-07 Chiesi Farmaceutici S.P.A. A pharmaceutical formulation for pressurised metered dose inhaler

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
CZ303833B6 (cs) * 2000-05-22 2013-05-22 Chiesi Farmaceutici S.P.A. Aerosolový prostredek
MXPA04008372A (es) * 2002-03-01 2004-11-26 Chiesi Farma Spa Formulacion superfina de formoterol.
US20040126325A1 (en) * 2002-03-12 2004-07-01 David Lewis Medicinal aerosol solution formulation products with improved chemical stability
EP1485443B1 (en) * 2002-03-18 2007-01-03 Bespak Plc Seal material for a dispensing apparatus
IL177103A0 (en) * 2004-02-27 2006-12-10 Chiesi Farma Spa Stable pharmaceutical solution formulations for pressurized metered dose inhalers
EP1595531A1 (en) * 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
EP1850831B1 (en) * 2005-02-25 2015-12-02 CHIESI FARMACEUTICI S.p.A. Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent

Also Published As

Publication number Publication date
MA28649B1 (fr) 2007-06-01
MXPA06013189A (es) 2007-02-14
BRPI0510852A (pt) 2007-11-27
WO2005112902A3 (en) 2006-05-04
IL178739A0 (en) 2007-02-11
US20070086953A1 (en) 2007-04-19
WO2005112902A2 (en) 2005-12-01
EP1746981A2 (en) 2007-01-31
ZA200608742B (en) 2008-07-30
AU2005245248A1 (en) 2005-12-01
CA2565747A1 (en) 2005-12-01
CN1950075A (zh) 2007-04-18
ES2309722T3 (es) 2008-12-16
EP1746981B1 (en) 2008-08-13
TNSN06334A1 (en) 2008-02-22
DE602005008946D1 (de) 2008-09-25
JP2007537170A (ja) 2007-12-20
ATE404185T1 (de) 2008-08-15
KR20070010159A (ko) 2007-01-22
EA200602112A1 (ru) 2007-04-27

Similar Documents

Publication Publication Date Title
MY143075A (en) Stable pharmaceutical solution formulations for pressurized metered dose inhalers.
ES2618829T3 (es) Sello para un aparato dispensador
NO20065722L (no) Medisinske aerosolformuleringsprodukter med forbedret kjemisk stabilitet.
DK0616525T3 (da) Medikamenter
EA033228B1 (ru) Находящаяся под давлением стабильная аэрозольная композиция комбинации гликопиррония бромида и формотерола в форме раствора
PE20011323A1 (es) Formulaciones farmaceuticas en solucion estable para inhaladores presurizados con medicion de dosis
ATE342053T1 (de) Formulierungen zur inhalation
NZ526564A (en) Metered dose inhaler for salmeterol xinafoate
BR112019005168A2 (pt) composição farmacêutica, recipiente vedado, inalador de dose medida, e, métodos para tratar um paciente que sofre ou susceptível de sofrer de um distúrbio respiratório, para melhoria da estabilidade de uma composição farmacêutica e do desempenho de aerossolização de uma composição farmacêutica e para reduzir o potencial de aquecimento global de uma composição farmacêutica
JP2024052867A (ja) 加圧分注容器
US20050241636A1 (en) Seal material for a dispensing apparatus
BR112012008983A2 (pt) "formulação medicinal em suspensão, composição farmacêutica, produto, uso de cromolina sódica,e, método para aumentar a estabilidade de uma formulação medicinal em suspensão de aerossol."
WO2005016410A3 (en) Pharmaceutical metered dose inhaler and methods relating thereto
BR112019005080A2 (pt) composição farmacêutica, recipiente vedado, inalador de dose medida, e, métodos para tratar um paciente sofrendo ou susceptível de sofrer de um distúrbio respiratório, para melhorar a estabilidade de uma composição farmacêutica, para aumentar o tempo de estabilização de uma composição farmacêutica, para melhorar o desempenho de aerossolização de uma composição farmacêutica e para reduzir o potencial de aquecimento global de uma composição farmacêutica.
WO2017021698A1 (en) Seal for a dispensing apparatus
GB2410500A (en) Seal for a pharmaceutical dispensing device
ATE375150T1 (de) Cyclodextrine als suspensionsstabilisatoren in druckverflüssigten treibmitteln
RU2800100C1 (ru) Раздаточный контейнер под давлением
GB2415699A (en) Seal material for a dispensing apparatus
BR0012907A (pt) Agente para o remédio de dano neural, composto contendo nitrogênio, e, composição farmacêutica
GB2445483A (en) Seal for a pharmaceutical dispensing device
BR112019005113A2 (pt) composição farmacêutica, recipiente vedado, inalador de dose medida, e, métodos para tratar um paciente que sofre ou susceptível a sofrer de um distúrbio respiratório, para melhorar a estabilidade de uma composição farmacêutica e para reduzir o potencial de aquecimento global de uma composição farmacêutica.
AR048418A1 (es) Formulaciones de soluciones medicinales estables para inhaladores de cartucho presurizados
BRPI0405842A (pt) composição farmacêutica estabilizada de composto flúor-éter para uso anestésico. método para estabilizar um composto flúor-éter. uso de agente estabilizante para impedir a degradação de composto flúor éter

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application